Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Nelson

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Biomaterials|December 20, 2014
ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial diseaseKristin M Poole, Christopher E Nelson, Rucha V Joshi, et al.
Molecular Pharmaceutics|January 22, 2013
Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micellesShann S Yu, Cheryl M Lau, Whitney J Barham, et al.
Advanced Healthcare Materials|October 8, 2016
Local Delivery of PHD2 siRNA from ROS-Degradable Scaffolds to Promote Diabetic Wound HealingJohn R Martin, Christopher E Nelson, Mukesh K Gupta, et al.
Nature Medicine|February 20, 2019
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophyChristopher E Nelson, Yaoying Wu, Matthew P Gemberling, et al.
Science (New York, N.Y.)|January 2, 2016
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophyChristopher E Nelson, Chady H Hakim, David G Ousterout, et al.
Nature Biotechnology|September 25, 2019
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cellsAdrian Pickar-Oliver, Joshua B Black, Mae M Lewis, et al.
JCI Insight|December 7, 2018
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic miceChady H Hakim, Nalinda B Wasala, Christopher E Nelson, et al.
Nature Communications|July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcomaJianguo Huang, Mark Chen, Melodi Javid Whitley, et al.
Nature Communications|November 25, 2021
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine modelsChady H Hakim, Sandeep R P Kumar, Dennis O Pérez-López, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biomaterials|December 20, 2014
ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial diseaseKristin M Poole, Christopher E Nelson, Rucha V Joshi, et al.
Molecular Pharmaceutics|January 22, 2013
Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micellesShann S Yu, Cheryl M Lau, Whitney J Barham, et al.
Advanced Healthcare Materials|October 8, 2016
Local Delivery of PHD2 siRNA from ROS-Degradable Scaffolds to Promote Diabetic Wound HealingJohn R Martin, Christopher E Nelson, Mukesh K Gupta, et al.
Nature Medicine|February 20, 2019
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophyChristopher E Nelson, Yaoying Wu, Matthew P Gemberling, et al.
Science (New York, N.Y.)|January 2, 2016
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophyChristopher E Nelson, Chady H Hakim, David G Ousterout, et al.
Nature Biotechnology|September 25, 2019
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cellsAdrian Pickar-Oliver, Joshua B Black, Mae M Lewis, et al.
JCI Insight|December 7, 2018
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic miceChady H Hakim, Nalinda B Wasala, Christopher E Nelson, et al.
Nature Communications|July 11, 2017
Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcomaJianguo Huang, Mark Chen, Melodi Javid Whitley, et al.
Nature Communications|November 25, 2021
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine modelsChady H Hakim, Sandeep R P Kumar, Dennis O Pérez-López, et al.
Pageof 4